Modeling considerations for in vivo quantification of the dopamine transporter using 11 CPE2I and positron emission tomography

Journal of Cerebral Blood Flow and Metabolism

Volumn 29, Issue 7, 2009, Pages 1332-1345

  DeLorenzo, Christine ^a,b   Kumar, Js Dileep ^b   Zanderigo, Francesca ^b   Mann, J John ^a,b   Parsey, Ramin V ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

11C PE2I; Compartment models; Dopamine transporter; Graphical models; Positron emission tomography

Indexed keywords

CARBON 11; DOPAMINE TRANSPORTER; N (3 IODOPROPENYL) 2BETA CARBOMETHOXY 3BETA (4 METHYLPHENYL)NORTROPANE C 11; NORTROPANE DERIVATIVE; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN REGION; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG UPTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; SIMULATION;

ADULT; CARBON RADIOISOTOPES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; LIGANDS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NORTROPANES; POSITRON-EMISSION TOMOGRAPHY;

EID: 67649874715     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2009.49     Document Type: Article

References (37)

1. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19:716-23
2. DeLorenzo C, Klein A, Mikhno A, Gray N, Zanderigo F, Man JJ, Parsey RV (2009) A new method for assessing PET-MRI coregistration. In: Proceedings of SPIE - Medical Imaging, Volume 7259
3. Drewes B, Sihver W, Willbold S, Olsson RA, Coenen HH (2007) New 2α-tropane amides as potential PET ligands for the dopamine transporter. Nucl Med Biol 34:531-9
4. Duvernoy HM (1991) The Human Brain: Surface, Three-Dimensional Sectional Anatomy and MRI. New York, NY: Springer-Verlag
5. Emond P, Guilloteau D, Chalon S (2008) PE2I: a radio-pharmaceutical for in vivo exploration of the dopamine transporter. CNS Neurosci Ther 14:47-64
6. Guilloteau D, Emond P, Baulieu JL, Garreau L, Frangin Y, Pourcelot L, Mauclaire L, Besnard JC, Chalon S (1998) Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′- methylphenyl)nortropane (PE2I). Nucl Med Biol 25:331-7
7. Gunn RN, Gunn SR, Turkheimer FE, Aston JAD, Cunningham VJ (2002) Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling. J Cereb Blood Flow Metab 22: 1425-39
8. 11C]WAY-100635 for PET. NeuroImage 8:426-40
9. 125I]PE2I. NeuroImage 9:108-16
10. 11C]WAY-100635. Brain Res 745:96-108
11. 11C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. Eur J Nucl Mol Imaging 30:1220-30
12. Herholz K (2004) NeuroPET: Positron Emission Tomography In Neuroscience And Clinical Neurology. Berlin, Germany: Springer-Verlag
13. 11C]PE2I: quantitative modeling and test-retest reproducibility. J Cereb Blood Flow Metab 28: 1059-69
14. Ito H, Takahashi H, Arakawa R, Takano H, Suhara T (2008) Normal database of dopaminergic transmission system in human brain measured by positron emission tomography. NeuroImage 39:555-65
15. 11C]PE2I binding to the dopamine transporter in the human brain: a PET study. Eur J Nucl Med Mol Imaging 33: 657-68
16. Kates WR, Abrams MT, Kaufmann WE, Breiter SN, Reiss AL (1997) Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome. Psychiatry Res: Neuroimaging 75:31-48
17. Killiany RJ, Moss MB, Nicholson T, Jolesz F, Sandor T (1997) An interactive procedure for extracting features of the brain from magnetic resonance images: the lobes. Hum Brain Mapp 5:355-63
18. Kuikka JT, Baulieu JL, Hiltunen J, Halldin C, Bergström KA, Farde L, Emond P, Chalon S, Yu M, Nikula T, Laitinen T, Karhu J, Tupala E, Hallikainen T, Kolemainen V, Mauclaire L, Maziere B, Tihonen J, Guilloteau D (1998) Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging. Eur J Nucl Med Mol Imaging 25:531-4
19. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. NeuroImage 4:153-8
20. Leroy C, Comtat C, Trébossen R, Syrota A, Martinot J, Ribeiro M (2007) Assessment of 11C-PE2I binding to the neuronal dopamine transporter in humans with the high-spatial-resolution PET scanner HRRT. J Nucl Med 48:538-46
21. Logan J, Fowler JS, Volkow ND, Ding YS, Wang G-J, Alexoff DL (2001) A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab 21:307-20
22. Logan J, Fowler JS, Volkow ND, Wang G-J, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834-40
23. Madras BK, Gracz LM, Meltzer PC, Liang AY, Elmaleh DR, Kaufman MJ, Fischman AJ (1998) Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to Dopamine-Rich Regions of Primate Brain. Synapse 29:105-15
24. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, Huang Y, Simpson N, Ngo K, Van Heertum R, Laruelle M (2001) Imaging human mesolimbic dopamine transmission with positron emission tomography. Part I: accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21:1034-57
25. Ogden RT (2003) Estimation of kinetic parameters in graphical analysis of PET imaging data. Stat Med 22:3557-68
26. 11C]DASB and positron emission tomography in humans: modeling considerations. J Cereb Blood Flow Metab 27:205-17
27. Ogden RT, Tarpey T (2006) Estimation in regression models with externally estimated parameters. Biostatistics 7:115-29
28. Parsey RV, Arango V, Olvet DM, Oquendo MA, Van Heertum RL, Mann JJ (2005) Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. J Cereb Blood Flow Metab 25:785-93
29. 11C]WAY-100635 in humans: comparison of arterial and reference tissue input functions. J Cereb Blood Flow Metab 20:1111-33
30. Shattuck DW, Mirza M, Adisetiyo V, Hojatkashani C, Salamon G, Narr KL, Poldrack RA, Bilder RM, Toga AW (2008) Construction of a 3D probabilistic atlas of human cortical structures. NeuroImage 39: 1064-80
31. 11C]PE2I. Eur J Nucl Med Mol Imaging 34:667-78
32. Slifstein M, Laruelle M (2000) Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J Nucl Med 41:2083-8
33. 11C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions. Nucl Med Biol 27:487-92
34. Späth H (1985) The Cluster Dissection and Analysis. Theory, FORTRAN programs, examples. Chichester, England: Ellis Horwood
35. Talairach J, Tournoux P (1988) Co-Planar Stereotaxic Atlas of the Human Brain: Three-Dimensional Proportional System. New York, NY: Thieme Medical
36. Watson CC, Newport D, Casey ME (1996) A single scatter simulation technique for scatter correction in 3D PET. In: Grangeat P, Amans J-L (eds). Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine. Dordrecht, The Netherlands: Kluwer Academic, pp 255-68
37. 123I]PE2I binding to dopamine transporters with SPECT. Eur J Nucl Med Mol Imaging 34:101-93